With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|LSD1 Inhibition to Treat T-cell Acute Lymphoblastic Leukemia/Lymphoma||University of Virginia, School of Medicine / Michael Engel, MD/PhD||Reach Grants||2016||Virginia|
|The TC3 Line, a Zebrafish Model of T-Cell Malignancy||Huntsman Cancer Institute / Nathan Meeker, MD||Young Investigator Grants||2008||Utah|
|Molecular diagnostic, prognostic, and therapeutic approaches toward Ewing sarcoma.||Huntsman Cancer Institute / Stephen Lessnick||Innovation Grants||2009||Utah|
|Determining Social Risk Factors for Poor Outcomes in Pediatric Cancer Using Children’s Oncology Group Registries||University of Utah / Anne Kirchhoff, PhD/MPH||Epidemiology Grants||2019||Utah|
|Identification of predisposition genes for Ewing sarcoma segregating in high-risk pedigrees||Huntsman Cancer Institute / Lisa Cannon-Albright, PhD||Innovation Grants||2012||Utah|
|Is SIRT5 a Therapy Target in Acute Lymphoblastic Leukemia?||University of Utah / Michael Deininger, MD/PhD||Innovation Grants||2018||Utah|
|A novel compound for treatment of T cell leukemia||Huntsman Cancer Institute / Nikolaus Trede||Innovation Grants||2010||Utah|
|GSTM4, a novel target for treating Ewing sarcoma.||Huntsman Cancer Institute / Wen Luo||Young Investigator Grants||2009||Utah|
|Targeting Metabolism in Alveolar Soft Part Sarcomagenesis||Huntsman Cancer Institute / Kevin Jones, MD||'A' Award Grants||2013||Utah|
|Comprehensive Analysis of Risk Factors for Pediatric Cancers Using the Utah Population Database||Huntsman Cancer Institute / Joshua Schiffman, MD||Epidemiology Grants||2010||Utah|